APOA1 and miotic rate: Moreover, novel class of drug like cholesterol-ester-transport-protein inhibitors (CETP) or intravenous Apo-A1-therapy, up-regulators of endogenous Apo-A1 production and Apo-A1 mimetic peptides deserve to be evaluated for MR treatment.